These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 33882078)

  • 1. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
    Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
    PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
    Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
    J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis.
    Brodsky J; Dougherty S; Makani R; Rubenstein RC; Kelly A
    Diabetes Care; 2011 Feb; 34(2):292-5. PubMed ID: 21228248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Tolerance in Patients with Cystic Fibrosis - Results from the German Cystic Fibrosis Registry.
    Prinz N; Wosniok J; Staab D; Ballmann M; Dopfer C; Regenfuß N; Rosenecker J; Schramm D; W RH; Nährlich L
    Klin Padiatr; 2020 Jul; 232(4):210-216. PubMed ID: 32176935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic Fibrosis-Related Diabetes Screening in Adults: A Gap Analysis and Evaluation of Accuracy of Glycated Hemoglobin Levels.
    Gilmour JA; Sykes J; Etchells E; Tullis E
    Can J Diabetes; 2019 Feb; 43(1):13-18. PubMed ID: 30173928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis.
    Cohen A; Mass A; Reiter J; Zangen DH; Cohen-Cymberknoh M
    Respir Med; 2024 Jul; 228():107664. PubMed ID: 38759874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study.
    Racine F; Shohoudi A; Boudreau V; Nguyen CQT; Denis MH; Desjardins K; Reynaud Q; Rabasa-Lhoret R; Mailhot G
    Can J Diabetes; 2021 Dec; 45(8):768-774. PubMed ID: 33926819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
    Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
    BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HbA1c as a screening tool for cystic fibrosis related diabetes.
    Burgess JC; Bridges N; Banya W; Gyi KM; Hodson ME; Bilton D; Simmonds NJ
    J Cyst Fibros; 2016 Mar; 15(2):251-7. PubMed ID: 25869326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
    Yung B; Kemp M; Hooper J; Hodson ME
    Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
    Gileles-Hillel A; Soesman LH; Miari S; Breuer O; Tsabari R; Elyashar-Earon H; Armoni S; Sprikkelman AB; Reiter J; Zangen D; Lavi E; Kerem E; Cohen-Cymberknoh M
    Pediatr Pulmonol; 2022 Nov; 57(11):2774-2780. PubMed ID: 35999051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
    Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
    Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes in cystic fibrosis: multicenter screening results based on current guidelines.
    Scheuing N; Holl RW; Dockter G; Fink K; Junge S; Naehrlich L; Smaczny C; Staab D; Thalhammer G; van Koningsbruggen-Rietschel S; Ballmann M
    PLoS One; 2013; 8(12):e81545. PubMed ID: 24324701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
    Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
    Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system.
    Schiaffini R; Brufani C; Russo B; Fintini D; Migliaccio A; Pecorelli L; Bizzarri C; Lucidi V; Cappa M
    Eur J Endocrinol; 2010 Apr; 162(4):705-10. PubMed ID: 20071479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.
    Lim WY; Ma S; Heng D; Tai ES; Khoo CM; Loh TP
    Sci Rep; 2018 Aug; 8(1):12419. PubMed ID: 30127499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes.
    Boudreau V; Coriati A; Desjardins K; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Mar; 15(2):258-60. PubMed ID: 26905501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring.
    Elidottir H; Diemer S; Eklund E; Hansen CR
    J Cyst Fibros; 2021 Sep; 20(5):779-784. PubMed ID: 33478894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.